Targeted and Personalized Therapy for Difficult Benign Brain Tumors: A Review
We support clinical decision-making that utilizes molecular profiling with functional testing to guide targeted treatment. We also identify evidence gaps such as biomarker-defined prospective trials that are needed for broader clinical implementation.
Authors
- Polina Chliapnikov
- Mark Bernstein
Institutions
- University Health Network (CA)
- Toronto Western Hospital (CA)
Publication Details
- Journal
- Journal of Personalized Medicine
- Published
- 2026-03-21
- DOI
- https://doi.org/10.3390/jpm16030170
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00